Newspaper logo  
 
 
Local Gov’t Stories, Events

Ref. : Civic Events

Ref. : Arts & Education Events

Ref. : Public Service Notices

Travel
Books, Films, Arts & Education

02.26 DeVos to Conservative Conference: I Will Replace the Bush-Obama Failed Ideas with My Own Failed Ideas

Letters

Ref. : Letters to the editor

Health Care & Environment

02.27 TRUMPCARE VS. OBAMACARE

02.27 Only China Can Save the Planet [Republicans cede renewable energy dominance to China, as if only fossil energy has worth. Could they be more stupid?]

02.27 With Obamacare in jeopardy, California considers going it alone with 'single-payer' system [with population larger than Canada, California could achieve better single-payer efficiencies than Canada's, with even greater efficiency when more states join in a common insurance market]

02.26 Windfarms aren’t the real reason energy bills are rising. Blame the free market

02.26 Food aid from warehouse to plate: fighting South Sudan’s famine – in pictures

02.26 Scott Pruitt vows to slash climate and water pollution regulations at CPAC [another immoral idiot speaks]

02.25 Revealed: thousands of children at London schools breathe toxic air [you can't see the most dangerous pollution, the particles are too small which makes them dangerous]

02.24 OMG measurements of Greenland give us a glimpse of future sea rise

02.24 Dutch minister calls on UK to join safe abortion fund after Trump ban

02.23 BREAKING: Exxon to Leave Up to 3.6 Billion Barrels of Tar Sands/Oil Sands in the Ground [Yay!]

02.23 Lancet Study on Life Expectancy by 2030 Confirms Poor US Performance

02.23 Climate scientists face harassment, threats and fears of 'McCarthyist attacks' [sociopathic behavior...]

02.23 The Case for a Fracking Ban

News Media Matters

02.26 Spurned Reporters should dump Trump Briefings, turn to Investigative Journalism

02.26 Revealed: how US billionaire helped to back Brexit [and Trump] [at what point is the label "traitor" apropriate?]

02.25 Donald Trump press ban: Guardian, BBC and CNN denied access to briefing

Daily: FAIR Blog
The Daily Howler

US Politics, Policy & 'Culture'

02.26 The Immigration Facts Donald Trump Doesn’t Like

02.26 'Incredibly Disappointing': Democrats Choose Tom Perez to Head Party [not changing is not the answer; can a party taking large campaign donations from healthcare companies ever support price-controlled single-payer?]

02.26 Trump national security adviser wants to avoid term 'radical Islamic terrorism', sources say [McMaster seems an unusually sane member of Trump's administration]

02.25 Wanted: Three Principled Republicans to Save America From Trump

02.25 REPUBLICANS ACCUSE VOTERS OF USING TOWN HALLS TO EXPRESS THEMSELVES

02.25 Resistance Recess Puts Congress on Notice for Supporting Trump’s Agenda

02.25 Steve Bannon: Trump is 'maniacally focused' on executing promises [videos; will increasingly unregulated and immoral capitalism save us?]

02.25 Donald Trump vows to 'get the bad people out' of US – as it happened

Justice Matters

02.26 The story of the week is Trump, Russia and the FBI. The rest is a distraction

02.26 Hate Crime Is Feared as 2 Indian Engineers Are Shot in Kansas [two foreigners walk into a red state bar...]

02.25 White House confirms conversation with FBI about Trump and Russia

High Crimes?
Economics, Crony Capitalism

02.25 Just as neoliberalism is finally on its knees, so too is the left

02.24 Michael Hudson: Why Failing to Solve Personal Debt and Polarization Will Usher in a New Dark Age

International

02.27 How Russia Is Using Oil Deals To Secure Its Influence In The Middle East [countries should get off of fossil fuels so the world can breathe]

02.27 Infographic: Here’s How the Global GDP Is Divvied Up

02.27 Twilight of the Technocrats? [caring for people and morals have to become prime factors!]

02.27 THE LONG HISTORY OF DEPORTATION SCARE TACTICS AT THE U.S.-MEXICO BORDER [why can't we have altruistic policy to help people avoid becoming refugees? perhaps it is bad governments that should be helped...or punished. is U.S. drug policy the root problem?]

02.26 HOW PETER THIEL’S PALANTIR HELPED THE NSA SPY ON THE WHOLE WORLD [technology East Germany's STASI would have loved!]

02.25 CHINA’S NORTH KOREA PROBLEM

02.25 TRUMP, PUTIN, AND THE NEW COLD WAR

02.25 Marine Le Pen refuses to be questioned by French police

02.24 A Global Counter-Trump Movement Is Taking Shape

02.24 UN: $4.4bn needed to prevent 'catastrophe' of famine

02.24 Kim Jong-nam killed by VX nerve agent, say Malaysian police

We are a non-profit Internet-only newspaper publication founded in 1973. Your donation is essential to our survival.

You can also mail a check to:
Baltimore News Network, Inc.
P.O. Box 42581
Baltimore, MD 21284-2581
Google
This site Web
  Big Pharma Wins Big in Health Care Reform

COMMENTARY:

Big Pharma Wins Big in Health Care Reform

by James Ridgeway
First published in his blog Unsilent Generation yesterday, 22 March 2010
To a large extent, the “debate” over health care was a show debate, an extended round of Washington smoke and mirrors. The administration early on cut its deal with Big Pharma, and pretty much stuck to it throughout the process.

The Republicans look a sour lot this morning, but the pharmaceutical industry, which helps foot the campaign bills of a sizeable chunk of members of both parties, is delighted with the legislation, and with its Democratic friends in the White House and on the Hill.

Members of Congress in both parties generally have lined up behind the insurance and pharmaceutical industries from the get go. So it should come as no surprise that the Democrats, who long ago gave up any pretence of opposing corporate power, found a way to accomodate the pharmaceutical companies on the way to its tepid reform. To a large extent, the “debate” over health care was a show debate, an extended round of Washington smoke and mirrors. The administration early on cut its deal with Big Pharma, and pretty much stuck to it throughout the process.

In fact, the Dems actually made the drugsters look good, celebrating the industry’s generous “concessions” and “discounts” while ensuring that no real threat to Big Pharma’s profits would make their way into the final bill.

The industry’s main goal from the very beginning has been to fend off any government power to negotiate or seriously regulate drug prices–and this they did.

Big Pharma’s second big win was to prevent any measure that would have opened the way for American consumers to buy less expensive drugs abroad, especially from Canada.

At the same time, the supposed give-backs by the drug industry are projected to more than pay for themselves. The much-lauded discounts on brand name drugs for seniors in the Medicare prescription drug program, for example, are good for Big Pharma because they discourage oldsters from switching to generics.

And more insured people simply mean more money coming into the coffers, for Big Pharma as well as for the insurance industry.

Confirmation of the industry analysis came early in the day from the stock market, where drug stocks initially remained level; there certainly was no rush to dump shares, which is what would be expected if the bill actually represented any threat to profits. And by 1 p, EST, CNN Money was reporting a rally in health care stocks.

“I was unable to find anything in there that would cause me to have anxiety if I were a shareholder in a pharmaceutical company,” Ira Loss, a senior health-care analyst at the research firm Washington Analysis, told Dow Jones. According to the ticker story:

Billy Tauzin, who led the industry’s negotiations on health care with lawmakers, said overall drug makers fare well. “While we’re not totally happy,” Tauzin began, “we generally feel like it tracks with our principles.”

Sanofi-Aventis SA (SNY) Chief Executive Christopher Viehbacher said in an interview that the impact of the legislation will be neutral to slightly negative “but better for the industry than if healthcare reform didn’t pass.”

Tauzin, head of the Pharmaceutical Research and Manufacturers of America or PhRMA, and Viehbacher said getting protection for brand-name biologics is among the important provisions for the industry. Drug makers pushed hard to get 12 years of exclusive market protection while the White House and some lawmakers wanted to lower the protection to seven years.

Despite fees and rebates imposed by the legislation, “analysts say drug makers will end up recouping those costs through new customers: The bill would provide insurance coverage to an additional 32 million Americans.” The Dow Jones story continues:

Chalk up another good round for Pharma and Biotech in health care reform,” began a note to clients Friday from Concept Capital, a research firm.Ken Tsuboi, co-manager of the Allianz RCM Wellness Fund, sees the impact of bill, and its $90 billion in concessions over 10 years, as relatively minor in an industry that has annual global sales of about $750 billion, with about $300 billion in the U.S., and margins close to 30%.”I think that it is actually a pretty good deal for Pharma,” Tsuboi said.

The GOP, which purports to be the party of big business, ought to be applauding at least these portions of the health care reform—and perhaps when the cameras go away, some of them will quit bitching and count their blessings. As for the obnoxious Tea Party gang, if they start threatening the real power in this country, which is vested in corporations, they may well find themselves whipped and isolated.


Born in 1936, James Ridgeway has been reporting on politics for more than 45 years. He is currently Senior Washington Correspondent for Mother Jones, and recently wrote a blog on the 2008 presidential election for the Guardian online. He previously served as Washington Correspondent for the Village Voice; wrote for Ramparts and The New Republic; and founded and edited two independent newsletters, Hard Times and The Elements.

Ridgeway is the author of 16 books, including The Five Unanswered Questions About 9/11, It’s All for Sale: The Control of Global Resources, and Blood in the Face: The Ku Klux Klan, Aryan Nations, Nazi Skinheads, and the Rise of a New White Culture. He co-directed a companion film to Blood in the Face and a second documentary film, Feed, and has co-produced web videos for GuardianFilms.

Additional information and samples of James Ridgeway’s work can be found at JamesRidgeway.net and at his newest web site, Solitary Watch.

This article is republished in the Baltimore Chronicle with permission of the author.



Copyright © 2010 The Baltimore News Network. All rights reserved.

Republication or redistribution of Baltimore Chronicle content is expressly prohibited without their prior written consent.

Baltimore News Network, Inc., sponsor of this web site, is a nonprofit organization and does not make political endorsements. The opinions expressed in stories posted on this web site are the authors' own.

This story was published on March 23, 2010.
 



Public Service Ads:
Verifiable Voting in Maryland